|
It was reported that a patient was hospitalized for pneumonia while using the synclara cough system therapy.The patient was subsequently discharged home, was reported to be doing well, and was cleared by the healthcare team to resume therapy.It was reported that the patient is nonverbal and frequently resisted therapy by fighting against the device, keeping his mouth closed, and holding his breath rather than following the intended inspiratory and expiratory therapy pattern.During treatment sessions, increased mucus production was reportedly observed, and therapy was paused to allow suctioning of secretions because the patient was unable to independently expectorate mucus.A baxter clinical support specialist coordinated retraining and recommended consultation with the patient's healthcare team to assess therapy effectiveness, review prescribed settings, and make any necessary adjustments to improve patient comfort and tolerance.There was no allegation or evidence of a device malfunction.The exact cause of the reported pneumonia remains unknown.Based on the available information, the event is most likely associated with the patient's underlying medical conditions and impaired respiratory status.The poor tolerance and resistance to synclara therapy, including failure to effectively participate in treatment and airway clearance activities, cannot be excluded as contributing factors.The device remains with the patient, who has been cleared to resume therapy following retraining and consultation with the healthcare team.No further information was available at the time of this report.
|